erbitux
- 网络西妥昔单抗;艾比特思;尔必得舒;西妥昔单抗注射液
erbitux-
Even patients who had a genetic profile favorable to Erbitux treatment showed no benefit by adding the drug to Avastin .
甚至根据有些病人的遗传概貌应用Erbitux治疗更合适，在将其添加至Avastin后也没显示出益处。
-
The222 patients treated with Erbitux and chemotherapy survived for an average of40 weeks .
接受艾比特思和化学疗法联合治疗的222名患者平均幸存了40周。
-
The company announced that the Canadian Medical service Administrative bureau authorizes the ERBITUX merge radiotherapy , partial treatment initial period pate tumor .
公司并宣布，加拿大医疗管理局批准ERBITUX合并放射疗法，局部治疗初期头颈部肿瘤。
-
Cetuxumab ( C225 , Erbitux ), a monoclonal antibody directed against ligand binding in the extracellular domain of EGFR , inhibits tumor growth and is synergistic with chemotherapy and radiation .
Cetuxumab（C225，erbitux）是一种单克隆抗体，可竞争性结合EGFR细胞外配体区，抑制肿瘤生长，与放化疗有协同作用。